Memorandum for the Deputy Attorney General: Recommendation for the Drug Enforcement Administration to Review whether its Field Offices are Engaging in Unlawful Fundraising on Behalf of the Drug Enforcement Administration Survivors Benefit Fund
- NARA ID
- memorandum-deputy-attorney-general-recommendation-drug-enforcement-administration-review
- Source
- oig-doj
- Collection
- DOJ OIG — Drug Enforcement Administration
- Agency
- U.S. DOJ Office of the Inspector General
- Classification
- Management Advisory Memorandum
- Released
- 2018-03-28
- Slug
- doj-oig-memorandum-deputy-attorney-general-recommendation-drug-enforcement-administration-review
- Indexed
- 2026-04-27 05:05:26
More from DOJ OIG — Drug Enforcement Administration
- Investigative Summary: Findings of Misconduct by a Drug Enforcement Administration Assistant Special Agent in Charge for Violating the Anti-Nepotism Statute and DEA Personal Conflict of Interest Policy
- Audit of the Drug Enforcement Administration’s Community-Based Efforts to Combat the Opioid Crisis
- Bonuses and Other Favorable Personnel Actions for Drug Enforcement Administration Employees Involved in Alleged Sexual Misconduct Incidents Referenced in the OIG's March 2015 Report
- Findings of Misconduct by a then Drug Enforcement Administration Regional Director for Misuse of Sensitive Investigative Unit Funds, Misuse of Representation Funds, Lack of Candor in Request for Representation Funds, and Related Misconduct
- Audit of the Drug Enforcement Administration's Spider Core System Pursuant to the Federal Information Security Modernization Act of 2014, Fiscal Year 2021
- The Drug Enforcement Administration's Clandestine Drug Laboratory Cleanup Program
Browse all 60 documents in DOJ OIG — Drug Enforcement Administration →
About the DOJ OIG — Drug Enforcement Administration collection
U.S. DOJ Office of the Inspector General reports (audits, investigations, evaluations, and reviews) concerning Drug Enforcement Administration.